Kenji Inoue
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kenji Inoue has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Yasumasa Fujiwara
Department of Cardiology, Juntendo University Nerima Hospital, Tokyo, Japan
3 shared publications- Chien-Chang Lee
Department of Emergency Medicine, National Taiwan University Hospital, Taipei, Taiwan.
2 shared publications Hiroyuki Daida
Department of Cardiology, Juntendo University School of Medicine, Tokyo, Japan
2 shared publicationsMasataka Sumiyoshi
Department of Cardiology, Juntendo University Nerima Hospital, Tokyo, Japan
2 shared publicationsMasayuki Shiozaki
Department of Cardiology, Juntendo University Nerima Hospital, Tokyo, Japan
2 shared publications- Akihiro Sato
Clinical Research Support Office, National Cancer Center Hospital East, Kashiwa, Japan
1 shared publication
Latest Publications
- 1 December 2020
- Published by Elsevier in International Journal of Cardiology
- Vol. 320, 1-6
Implementing the European Society of Cardiology 0-h/1-h algorithm in patients presenting very early after chest pain
- 1 December 2020
- Published by Elsevier in International Journal of Cardiology
- Vol. 320, 1-6
Implementing the European Society of Cardiology 0-h/1-h algorithm in patients presenting very early after chest pain
- 1 December 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 249, 32-35
Utility of the 0-hour/1-hour high-sensitivity cardiac troponin T algorithm in Asian patients with suspected non-ST elevation myocardial infarction
- 1 December 2017
- Published by Elsevier in International Journal of Cardiology
- Vol. 249, 32-35
Utility of the 0-hour/1-hour high-sensitivity cardiac troponin T algorithm in Asian patients with suspected non-ST elevation myocardial infarction
- 1 February 2010
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 1 (1) , e28-e32
Infective endocarditis associated with acute myocardial infarction caused by septic emboli
- 1 February 2010
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 1 (1) , e28-e32
Infective endocarditis associated with acute myocardial infarction caused by septic emboli
- 1 January 2009
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 47 (4) , 471-477
Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations
The aim of this study was to evaluate the distribution of pentraxin 3 (PTX3) values in healthy subjects and to characterize its relationship with gender, age, body mass index (BMI), lipid profile, and blood sugar levels. A Japanese population of 1749 healthy subjects (818 men and 931 women) with a mean (SD) age of 59.6 (11.4) years (range 37-87 years) were examined. Plasma PTX3 levels (PTX3 data are expressed as the geometric mean and confidence intervals) were i) significantly lower in men than in women (1.87 [1.81, 1.94] ng/mL vs. 2.12 [2.05, 2.19] ng/mL, p<0.0001), ii) significantly higher in the high age group (men, lowest quartile 1.62 [1.50, 1.74] ng/mL vs. highest quartile 2.14 [2.02, 2.27] ng/mL, p<0.001; women, lowest quartile 2.05 [1.92, 2.18] ng/mL vs. highest quartile 2.23 [2.02, 2.46] ng/mL, p<0.05), iii) inversely correlated with triglycerides (r=-0.19 in men and r=-0.18 in women, p<0.00001), and BMI (r=-0.16 in men and r=-0.24 in women, p<0.00001), and iv) lower in subjects with metabolic syndrome (MetS) than in the absence of MetS (1.82 [1.70, 1.95] ng/mL vs. 2.11 [2.06, 2.16] ng/mL, p=0.021). We defined the normal range of plasma PTX3 in healthy Japanese subjects, and also showed the relationship between plasma PTX3 levels and established coronary risk factors, including MetS. PTX3 could be an ideal biomarker because it is a marker relatively independent from established coronary risk factors.
- 1 January 2009
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 47 (4) , 471-477
Determination of physiological plasma pentraxin 3 (PTX3) levels in healthy populations
The aim of this study was to evaluate the distribution of pentraxin 3 (PTX3) values in healthy subjects and to characterize its relationship with gender, age, body mass index (BMI), lipid profile, and blood sugar levels. A Japanese population of 1749 healthy subjects (818 men and 931 women) with a mean (SD) age of 59.6 (11.4) years (range 37-87 years) were examined. Plasma PTX3 levels (PTX3 data are expressed as the geometric mean and confidence intervals) were i) significantly lower in men than in women (1.87 [1.81, 1.94] ng/mL vs. 2.12 [2.05, 2.19] ng/mL, p<0.0001), ii) significantly higher in the high age group (men, lowest quartile 1.62 [1.50, 1.74] ng/mL vs. highest quartile 2.14 [2.02, 2.27] ng/mL, p<0.001; women, lowest quartile 2.05 [1.92, 2.18] ng/mL vs. highest quartile 2.23 [2.02, 2.46] ng/mL, p<0.05), iii) inversely correlated with triglycerides (r=-0.19 in men and r=-0.18 in women, p<0.00001), and BMI (r=-0.16 in men and r=-0.24 in women, p<0.00001), and iv) lower in subjects with metabolic syndrome (MetS) than in the absence of MetS (1.82 [1.70, 1.95] ng/mL vs. 2.11 [2.06, 2.16] ng/mL, p=0.021). We defined the normal range of plasma PTX3 in healthy Japanese subjects, and also showed the relationship between plasma PTX3 levels and established coronary risk factors, including MetS. PTX3 could be an ideal biomarker because it is a marker relatively independent from established coronary risk factors.